Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

NCT07680439 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Intrinsic Pontine Glioma
DIPG
Brain Tumor
CNS Tumor
Central Nervous System Tumor
Pediatric Cancer
Adult Cancer Patients
CNS Tumor, Childhood
CNS Tumor, Adult
Brainstem Glioma
Diffuse Midline Glioma
DMG

Interventions

BIOLOGICAL: BCB-276

Sponsor

BrainChild Bio, Inc